bmi requirement for glp 1 Who Qualifies Semaglutide GLP-1 Injections for Weight Loss? Who Is a Good Candidate

Over a relatively short period, obesity and type 2 diabetes have come to represent a large medical and economic burden to global societies

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

A recent study shows that metabolic surgery delivers more effective and durable obesity outcomes than GLP-1 therapy, where real-world discontinuation exceeds 5070%

Surgery timing with GLP-1 therapy requires careful planning

Moreover, to account for possible confounders, adjusted ORs (mainly based on age, sex, body mass index [BMI], diabetes) were pooled and analyzed

Tirzepatide 10mg research peptide